Silicon and matrix macromolecules: new research opportunities for old diseases from analysis of potential mechanisms of breast implant toxicity.
An understanding of the normal and essential integration of the element silicon in biosystems, as well as knowledge of its fundamental chemistry, are crucial to understanding its role in health and disease. Modern organosilicon chemistry, based in part on the artificial silicon-carbon bond, coincided with the emergence of the biomaterials and bioengineering fields fifty years ago, and was thought to be a fortunate coincidence according to conventional wisdom that high-molecular-weight polymeric siloxanes were chemically and biologically inert. These concepts have been challenged by reports of silicone migration and degradation following insertion of gel-filled breast implants, claims of a novel systemic illness appearing in many breast implant recipients, and investigations implicating varied and permeating immunotoxic mechanisms of disease causation by breast devices. The present study develops additional potential pathogenetic ideas based on alterations of cell biochemistry by silicon-containing compounds, and offers correlation of the patients' diverse clinical features with plausable disruption of basic biological processes. This in turn raises new questions concerning everyday environmental exposure, has broad implications for multiple other diseases, can provide alternative directions for future investigative research, and may contribute to the ongoing redefinition of immune dysfunction and inflammation.
Brawer
A E
AE
Department of Medicine, Monmouth Medical Center, Long Branch, New Jersey, USA.
D001672:Biocompatible Materials / Q000009:adverse effects*; D018427:Breast Implants / Q000009:adverse effects*; D005109:Extracellular Matrix / Q000502:physiology*; D005260:Female; D006025:Glycosaminoglycans / Q000502:physiology*; D006801:Humans; D008407:Mast Cells / Q000502:physiology; D008954:Models, Biological; D012825:Silicon / Q000009:adverse effects*; D012833:Siloxanes / Q000009:adverse effects
D001672:Biocompatible Materials; D006025:Glycosaminoglycans; D012833:Siloxanes; D012825:Silicon